There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...

A hallmark of Alzheimer's is the accumulation of beta-amyloid protein in the brain, which is linked to cell death ...

The failure to diagnose Alzheimer's disease—the most common form of dementia in the elderly—at an early stage of molecular ...

GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...

Amyloid-beta and tau proteins have long been associated with Alzheimer's disease. The pathological buildup of these proteins ...

The GE HealthCare imaging tool is coming out as pharma companies release new therapies onto the market to help treat the ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

Two University of Wyoming faculty members will study how to understand the microcircuit changes that occur in the brain’s prefrontal cortex during normal aging as well as disease progression in ...

A study published Wednesday in Nature Neuroscience sheds light into how amyloid-beta and tau proteins impact brain activity ...

This year's World Alzheimer's Day campaign aims to address the stigma and discrimination while highlighting global efforts to ...